diagnostics

Editorial

New Technology in Medicine: How Much Should We Rely On It?

03/03/2020

Terry Treadwell , MD, FACS, FAAWC;

03/03/2020

Wounds

Pharma Insights

Companion Diagnostics and Complementary Diagnostics in Clinical Practice: Better Medicine or Competitive Disadvantage?

05/06/2016

David Parker , PhD;

Larry Blandford , PharmD;

We are pleased to present the second installment in our recurring column, Pharma Insights. This month we take a look at an interesting twist in how the use of complementary and companion diagnostics is playing out in...

We are...

05/06/2016

Journal of Clinical Pathways

Research in Review

Gene-Expression Test Cost-Effective for Determining Unknown Tumor Origins

03/31/2016

JCP Editors

The 2000-gene-expression profiling (GEP) test may be a more cost-effective option than current strategies for identifying tumor origin in patients with cancer of unknown primary (CUP), a recent study...

The...

03/31/2016

Journal of Clinical Pathways